✦ LIBER ✦

The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico

✍ Scribed by Bertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A.; de la Torre, L.; Gonzalez, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Bendamustine Versu

✍ Bertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; G 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost/Benefit Analysis of First Line Chro

✍ Wehler, E.; Leyva, V.; Bertwistle, D.; Munakata, J.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN90 Cost Effectiveness Analysis of Ben

✍ S. Vandekerckhove; K. Holtzer-Goor; D. Van Den Steen; Y. van Megen; P. Huijgens; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-effectiveness of adding rituximab t

✍ Hornberger, John; Reyes, Carolina; Shewade, Ashwini; Lerner, Susan; Friedmann, M 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 369 KB

PCN32 COST-MINIMIZATION ANALYSIS OF ORAL

✍ G Araujo; M Fonseca; R Bigni 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PCN93 COST-EFFECTIVENESS ANALYSIS OF BEN

✍ J Malin; T Kongnakorn; J Sterchele; C Salvador; D Getsios; M Mwamburi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB